Outcomes of balloon dilation for paediatric laryngeal stenosis.


Journal

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale
ISSN: 1827-675X
Titre abrégé: Acta Otorhinolaryngol Ital
Pays: Italy
ID NLM: 8213019

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 05 05 2020
accepted: 28 07 2020
entrez: 10 12 2020
pubmed: 11 12 2020
medline: 19 8 2021
Statut: ppublish

Résumé

Balloon dilation (BD) is a minimally invasive endoscopic treatment for paediatric laryngeal stenosis (LS) with reduced morbidity compared to open surgery. We retrospectively describe our experience in a cohort of children with chronic LS. Fourteen children (median age: 28.5; range: 2-81 months) with chronic LS (multilevel in 8) were treated with tubeless total intravenous anaesthesia under spontaneous ventilation. Grade III LS was preoperatively detected in 12 children; the remaining 2 had grade IV stenosis. Six had prior tracheotomy, and one received it during the first intervention. Dilation laryngoplasty was the primary treatment in 11 children and was used as an adjuvant treatment in 3 after open reconstructive surgery. The median number of dilations was 2 (range: 1-6). There were no postoperative complications. At the end of the follow-up (median: 20.5; range: 2-46 months), detectable laryngeal lumen widening and/or respiratory improvement occurred in 12 children. Two of 7 patients with tracheostomy were decannulated. Balloon laryngoplasty is a valuable therapeutic option to improve laryngeal patency in children with chronic multilevel LS, both as a primary and secondary adjuvant treatment after reconstructive surgery. Il balloon nel trattamento delle stenosi laringee in età pediatrica. Descrivere retrospettivamente la nostra esperienza con dilatazione laringea con balloon (DB) per il trattamento della stenosi laringea (SL) cronica in età pediatrica. Quattordici bambini (età mediana: 28,5; range: 2-81 mesi) con SL cronica (multi-livello in 8 casi) sono stati sottoposti a DB in ventilazione spontanea in assenza di intubazione orotracheale con anestesia endovenosa esclusiva. Dodici bambini presentavano pre-operatoriamente una SL di grado III, i rimanenti una SL di grado IV. Sei pazienti erano portatori di tracheotomia mentre un paziente è stato sottoposto a tracheotomia durante la prima DB. La DB è stata eseguita come trattamento primario in 11 bambini e come adiuvante a chirurgia ricostruttiva in 3 casi. Il numero mediano di BD eseguite è 2 (range: 1-6). Non si sono verificate complicanze post-operatorie e, al termine del follow-up (mediana: 20,5; range: 2-46 mesi), in 12 bambini è stato obiettivato un ampliamento del lume laringeo e/o un miglioramento respiratorio. Due dei 7 pazienti con tracheotomia sono stati decannulati con successo. La DB risulta efficace e sicura per migliorare in bambini con SL cronica multi-livello sia come trattamento primario che come trattamento adiuvante.

Autres résumés

Type: Publisher (ita)
Il balloon nel trattamento delle stenosi laringee in età pediatrica.

Identifiants

pubmed: 33299226
doi: 10.14639/0392-100X-N0830
pmc: PMC7726638
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

360-367

Informations de copyright

Copyright © 2020 Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Rome, Italy.

Références

JAMA Otolaryngol Head Neck Surg. 2014 Oct;140(10):901-5
pubmed: 25170960
Eur Arch Otorhinolaryngol. 2018 Sep;275(9):2325-2331
pubmed: 30008140
Am J Otolaryngol. 2016 Nov - Dec;37(6):490-492
pubmed: 27968957
AJR Am J Roentgenol. 1984 Mar;142(3):477-8
pubmed: 6607627
Otolaryngol Head Neck Surg. 2000 Jan;122(1):61-3
pubmed: 10629484
Laryngoscope. 2014 Jul;124(7):1707-12
pubmed: 24222273
Ann Otol Rhinol Laryngol. 1994 Apr;103(4 Pt 1):319-23
pubmed: 8154776
J Laryngol Otol. 1995 Sep;109(9):876-9
pubmed: 7494126
Arch Otolaryngol Head Neck Surg. 2007 Aug;133(8):772-5
pubmed: 17709614
Otolaryngol Head Neck Surg. 2008 Oct;139(4):551-9
pubmed: 18922343
Expert Rev Respir Med. 2018 Aug;12(8):709-717
pubmed: 29969925
J Pediatr Surg. 2013 Aug;48(8):1676-81
pubmed: 23932606
J Laryngol Otol. 2017 Mar;131(3):268-272
pubmed: 28095939
Int J Pediatr Otorhinolaryngol. 2015 Apr;79(4):532-6
pubmed: 25677564
J Pediatr Surg. 1991 Aug;26(8):957-61
pubmed: 1919989
Ann Otol Rhinol Laryngol Suppl. 1985 Nov-Dec;121:2-16
pubmed: 3935032
Int J Pediatr Otorhinolaryngol. 2016 Feb;81:1-4
pubmed: 26810279

Auteurs

Giovanna Cantarella (G)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Department of Otolaryngology and Head and Neck Surgery, Milan, Italy.
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Michele Gaffuri (M)

Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Sara Torretta (S)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Department of Otolaryngology and Head and Neck Surgery, Milan, Italy.
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Simona Neri (S)

Unit of Pediatric Anesthesiology and Intensive Care, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Maria Teresa Ambrosini (MT)

Unit of Pediatric Anesthesiology and Intensive Care, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Alessandra D'Onghia (A)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Department of Otolaryngology and Head and Neck Surgery, Milan, Italy.
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Lorenzo Pignataro (L)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Department of Otolaryngology and Head and Neck Surgery, Milan, Italy.
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Kishore Sandu (K)

Airway Sector; Department of Otolaryngology, Lausanne University Hospital CHUV, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH